Position in ACRS
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$110,456
New position
Shares Held
29,455
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Diversified Trust Co holds $26,966,050 across 29 Biotechnology names. ACRS ranks #24 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
37,161 | $8,499,835 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
43,971 | $3,265,286 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,553 | $2,166,473 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,504 | $1,934,690 | |
| 5 | INCY |
Incyte Corp
|
14,164 | $1,333,115 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
18,557 | $1,264,288 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
44,842 | $998,182 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
10,745 | $992,623 |
All Filings in ACRS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $110,456 | 29,455 | Shares | Sole | 2026-04-16 | |
| No filing history on record for this holder in this stock. | ||||||